Is TYRA or VANI more undervalued in 2026?

CirclFi compares Tyra Biosciences, Inc. (TYRA) and Vivani Medical, Inc. (VANI) using 13 institutional-grade valuation models. TYRA has a Quality of Company score of 4.3/10 while VANI scores 4.4/10.

Which is a better buy — TYRA or VANI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TYRA and VANI valuations compare?

TYRA at $32.68 and VANI at $1.29 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TYRA vs VANI Valuation Comparison 2026 — Intrinsic Value Analysis

TYRA

Biotechnology

Tyra Biosciences, Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$32.68

Last close

Models

7/13

Active

VANI

Biotechnology

Vivani Medical, Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$1.29

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	TYRA Fair Value	TYRA Upside	VANI Fair Value	VANI Upside
Bayesian DCF	Intrinsic	$9.52	-70.9%	$0.39	-70.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$5.32	-83.7%	$0.43	-66.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TYRA vs VANI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TYRA vs VANI — Which Stock Is More Undervalued?

VANI scores higher with a 4.4/10 quality rating vs TYRA's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tyra Biosciences, Inc. (TYRA) and Vivani Medical, Inc. (VANI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TYRA currently trades at $32.68 with a QOC of 4.3/10, while VANI trades at $1.29 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).